Mesenchymal stromal cells to treat patients with non‐ischaemic heart failure: Results from SCIENCE II pilot study

Abstract Aims Allogeneic stem cell therapy is more logistically suitable compared with autologous cell therapy for large‐scale patient treatment. We aim to investigate the clinical safety and efficacy profile of the allogeneic adipose tissue derived mesenchymal stromal cell product (CSCC_ASC) as an...

Full description

Bibliographic Details

Published in:	ESC Heart Failure
Main Authors:	Abbas Ali Qayyum, Sabina Frljak, Morten Juhl, Gregor Poglajen, Gregor Zemljičl, Andraz Cerar, Thomas Litman, Annette Ekblond, Mandana Haack‐Sørensen, Lisbeth Drozd Højgaard, Jens Kastrup, Bojan Vrtovec
Format:	Article
Language:	English
Published:	Wiley 2024-12-01
Subjects:	Adipose tissue derived mesenchymal stromal cells Allogeneic therapy Clinical trial Heart failure Stem cells
Online Access:	https://doi.org/10.1002/ehf2.14925